Sign In

Derrell Porter

Founder & CEO at Cellevolve Bio

Dr. Derrell D. Porter is a physician-entrepreneur and biopharmaceutical executive with over 20 years of experience in drug development, commercialization, and corporate strategy. He is currently the Chief Executive Officer of CTRL Therapeutics, a company focused on next-generation cell therapies for solid tumors, and serves as a Board Member at Portal Innovations, LLC, a venture development firm supporting early-stage biotech companies. Additionally, he holds board positions at Acumen Pharmaceuticals and Passage Bio.123

Dr. Porter previously founded Cellevolve Bio, a biotech company focused on cell therapy for neglected diseases. His career includes leadership roles at prominent companies such as Gilead Sciences, AbbVie, Amgen, and Atara Biotherapeutics. He has expertise in global commercialization and strategic development across various therapeutic areas.13

He earned his M.D. from the Perelman School of Medicine at the University of Pennsylvania, an MBA from The Wharton School, and a bachelor’s degree in psychobiology and neuroscience from UCLA.12

Highlights

Portal Team - Portal Innovations
Portal Team - Portal Innovations
Acumen Pharmaceuticals Appoints Derrell Porter, M.D., to
Jan 23 · marketscreener.com
Derrell Porter: Positions, Relations and Network - MarketScreener

Related Questions

What are Derrell Porter's main responsibilities at Portal Innovations, LLC?
How did Derrell Porter transition from a CEO role to a board member position?
What are some notable achievements of Derrell Porter in the pharmaceutical industry?
How does Derrell Porter's educational background influence his career in biotechnology?
What are the key projects Derrell Porter is currently involved in at Passage Bio, Inc?
Derrell Porter
Derrell Porter, photo 1
Derrell Porter, photo 2
Add to my network

Location

San Francisco, California, United States